Click here to get full coverage on United Therapeutics (UTHR) Surges 10.7%: Is This an Indication of Further Gains? - Yahoo Finance

United Therapeutics (UTHR) Surges 10.7%: Is This an Indication of Further Gains?  Yahoo Finance

United Therapeutics (UTHR) Surges 10.7%: Is This an Indication of Further Gains? - Yahoo Finance

Click here to get full coverage on Avoiding Lag: Real-Time Signals in (UTHR) Movement - Stock Traders Daily

Avoiding Lag: Real-Time Signals in (UTHR) Movement  Stock Traders Daily

Avoiding Lag: Real-Time Signals in (UTHR) Movement - Stock Traders Daily

Click here to get full coverage on Martine Rothblatt Sells 9,500 Shares of United Therapeutics (NASDAQ:UTHR) Stock - MarketBeat

Martine Rothblatt Sells 9,500 Shares of United Therapeutics (NASDAQ:UTHR) Stock  MarketBeat

Martine Rothblatt Sells 9,500 Shares of United Therapeutics (NASDAQ:UTHR) Stock - MarketBeat

Click here to get full coverage on United Therapeutics sends $1.5B upfront for stock, $500M left - Stock Titan

United Therapeutics sends $1.5B upfront for stock, $500M left  Stock Titan

United Therapeutics sends $1.5B upfront for stock, $500M left - Stock Titan

Click here to get full coverage on What United Therapeutics (UTHR)'s Ralinepag Phase 3 Win and $2 Billion Buyback Mean For Shareholders - simplywall.st

What United Therapeutics (UTHR)'s Ralinepag Phase 3 Win and $2 Billion Buyback Mean For Shareholders  simplywall.st

What United Therapeutics (UTHR)'s Ralinepag Phase 3 Win and $2 Billion Buyback Mean For Shareholders - simplywall.st

Click here to get full coverage on Causey (United Therapeutics) sells $9803 in UTHR stock - Investing.com

Causey (United Therapeutics) sells $9803 in UTHR stock  Investing.com

Causey (United Therapeutics) sells $9803 in UTHR stock - Investing.com

Click here to get full coverage on United Therapeutics Corp (UTHR) Shares Up 8.91% on Mar 9 - GuruFocus

United Therapeutics Corp (UTHR) Shares Up 8.91% on Mar 9  GuruFocus

United Therapeutics Corp (UTHR) Shares Up 8.91% on Mar 9 - GuruFocus

Click here to get full coverage on UTHR: Record clinical results, new inhalers, and AI-driven R&D fuel growth and innovation through 2028 - TradingView

UTHR: Record clinical results, new inhalers, and AI-driven R&D fuel growth and innovation through 2028  TradingView

UTHR: Record clinical results, new inhalers, and AI-driven R&D fuel growth and innovation through 2028 - TradingView

Click here to get full coverage on United Therapeutics jumps on $2B buyback authorization and accelerated repurchase - Quiver Quantitative

United Therapeutics jumps on $2B buyback authorization and accelerated repurchase  Quiver Quantitative

United Therapeutics jumps on $2B buyback authorization and accelerated repurchase - Quiver Quantitative

Click here to get full coverage on United Therapeutics's board approves new $2B repurchase authorization; prices $1.5B ASR - Seeking Alpha

United Therapeutics's board approves new $2B repurchase authorization; prices $1.5B ASR  Seeking Alpha

United Therapeutics's board approves new $2B repurchase authorization; prices $1.5B ASR - Seeking Alpha

Click here to get full coverage on United Therapeutics (NASDAQ:UTHR) Sets New 1-Year High - Here's What Happened - MarketBeat

United Therapeutics (NASDAQ:UTHR) Sets New 1-Year High - Here's What Happened  MarketBeat

United Therapeutics (NASDAQ:UTHR) Sets New 1-Year High - Here's What Happened - MarketBeat

Click here to get full coverage on Assessing United Therapeutics (UTHR) Valuation After Mixed Short-Term Returns And Strong Long-Term Gains - simplywall.st

Assessing United Therapeutics (UTHR) Valuation After Mixed Short-Term Returns And Strong Long-Term Gains  simplywall.st

Assessing United Therapeutics (UTHR) Valuation After Mixed Short-Term Returns And Strong Long-Term Gains - simplywall.st

Click here to get full coverage on UTHR: Breakthroughs in pulmonary disease, new inhalers, and AI-driven R&D fuel strong growth outlook - TradingView

UTHR: Breakthroughs in pulmonary disease, new inhalers, and AI-driven R&D fuel strong growth outlook  TradingView

UTHR: Breakthroughs in pulmonary disease, new inhalers, and AI-driven R&D fuel strong growth outlook - TradingView

Click here to get full coverage on United Therapeutics (UTHR) Announces $2 Billion Stock Buyback In - GuruFocus

United Therapeutics (UTHR) Announces $2 Billion Stock Buyback In  GuruFocus

United Therapeutics (UTHR) Announces $2 Billion Stock Buyback In - GuruFocus

Click here to get full coverage on Assessing United Therapeutics (UTHR) Valuation After Strong Earnings And Pipeline Updates - Yahoo Finance

Assessing United Therapeutics (UTHR) Valuation After Strong Earnings And Pipeline Updates  Yahoo Finance

Assessing United Therapeutics (UTHR) Valuation After Strong Earnings And Pipeline Updates - Yahoo Finance

Click here to get full coverage on United Therapeutics Corporation $UTHR Position Trimmed by Barclays PLC - MarketBeat

United Therapeutics Corporation $UTHR Position Trimmed by Barclays PLC  MarketBeat

United Therapeutics Corporation $UTHR Position Trimmed by Barclays PLC - MarketBeat

Click here to get full coverage on Is It Time To Reassess United Therapeutics (UTHR) After Its Recent Share Price Volatility - simplywall.st

Is It Time To Reassess United Therapeutics (UTHR) After Its Recent Share Price Volatility  simplywall.st

Is It Time To Reassess United Therapeutics (UTHR) After Its Recent Share Price Volatility - simplywall.st

Click here to get full coverage on Is It Too Late To Consider United Therapeutics (UTHR) After Its Strong Multi Year Rally? - Yahoo Finance

Is It Too Late To Consider United Therapeutics (UTHR) After Its Strong Multi Year Rally?  Yahoo Finance

Is It Too Late To Consider United Therapeutics (UTHR) After Its Strong Multi Year Rally? - Yahoo Finance

Click here to get full coverage on WINTON GROUP Ltd Makes New Investment in United Therapeutics Corporation $UTHR - MarketBeat

WINTON GROUP Ltd Makes New Investment in United Therapeutics Corporation $UTHR  MarketBeat

WINTON GROUP Ltd Makes New Investment in United Therapeutics Corporation $UTHR - MarketBeat

Click here to get full coverage on Grantham Mayo Van Otterloo & Co. LLC Acquires 6,079 Shares of United Therapeutics Corporation $UTHR - MarketBeat

Grantham Mayo Van Otterloo & Co. LLC Acquires 6,079 Shares of United Therapeutics Corporation $UTHR  MarketBeat

Grantham Mayo Van Otterloo & Co. LLC Acquires 6,079 Shares of United Therapeutics Corporation $UTHR - MarketBeat

Click here to get full coverage on Why United Therapeutics (UTHR) Shares Are Sliding Today - Yahoo Finance

Why United Therapeutics (UTHR) Shares Are Sliding Today  Yahoo Finance

Why United Therapeutics (UTHR) Shares Are Sliding Today - Yahoo Finance

Click here to get full coverage on United Therapeutics (NASDAQ:UTHR) Director Sells $978,840.00 in Stock - MarketBeat

United Therapeutics (NASDAQ:UTHR) Director Sells $978,840.00 in Stock  MarketBeat

United Therapeutics (NASDAQ:UTHR) Director Sells $978,840.00 in Stock - MarketBeat

Click here to get full coverage on UTHR Tops Q4 Earnings Estimates, Shares Surge 13% on Strong Guidance - Yahoo Finance

UTHR Tops Q4 Earnings Estimates, Shares Surge 13% on Strong Guidance  Yahoo Finance

UTHR Tops Q4 Earnings Estimates, Shares Surge 13% on Strong Guidance - Yahoo Finance

Click here to get full coverage on USNA or UTHR: Which Is the Better Value Stock Right Now? - Yahoo Finance

USNA or UTHR: Which Is the Better Value Stock Right Now?  Yahoo Finance

USNA or UTHR: Which Is the Better Value Stock Right Now? - Yahoo Finance

Click here to get full coverage on H.C. Wainwright Raises United Therapeutics (UTHR) Target to $600 - Yahoo Finance

H.C. Wainwright Raises United Therapeutics (UTHR) Target to $600  Yahoo Finance

H.C. Wainwright Raises United Therapeutics (UTHR) Target to $600 - Yahoo Finance

Click here to get full coverage on United Therapeutics (NASDAQ:UTHR) Misses Q4 CY2025 Revenue Estimates - Yahoo Finance

United Therapeutics (NASDAQ:UTHR) Misses Q4 CY2025 Revenue Estimates  Yahoo Finance

United Therapeutics (NASDAQ:UTHR) Misses Q4 CY2025 Revenue Estimates - Yahoo Finance

Click here to get full coverage on Rhenman & Partners Asset Management AB Buys Shares of 8,000 United Therapeutics Corporation $UTHR - MarketBeat

Rhenman & Partners Asset Management AB Buys Shares of 8,000 United Therapeutics Corporation $UTHR  MarketBeat

Rhenman & Partners Asset Management AB Buys Shares of 8,000 United Therapeutics Corporation $UTHR - MarketBeat

Click here to get full coverage on Compared to Estimates, United Therapeutics (UTHR) Q4 Earnings: A Look at Key Metrics - Yahoo Finance

Compared to Estimates, United Therapeutics (UTHR) Q4 Earnings: A Look at Key Metrics  Yahoo Finance

Compared to Estimates, United Therapeutics (UTHR) Q4 Earnings: A Look at Key Metrics - Yahoo Finance

Click here to get full coverage on United Therapeutics Corporation Announces $2 Billion Stock Repurchase - citybiz

United Therapeutics Corporation Announces $2 Billion Stock Repurchase  citybiz

United Therapeutics Corporation Announces $2 Billion Stock Repurchase - citybiz

Click here to get full coverage on United Therapeutics (UTHR) Surpasses Q4 Earnings Estimates - Nasdaq

United Therapeutics (UTHR) Surpasses Q4 Earnings Estimates  Nasdaq

United Therapeutics (UTHR) Surpasses Q4 Earnings Estimates - Nasdaq

Click here to get full coverage on United Therapeutics (NASDAQ:UTHR) EVP Paul Mahon Sells 8,300 Shares - MarketBeat

United Therapeutics (NASDAQ:UTHR) EVP Paul Mahon Sells 8,300 Shares  MarketBeat

United Therapeutics (NASDAQ:UTHR) EVP Paul Mahon Sells 8,300 Shares - MarketBeat

Click here to get full coverage on Insider Selling: United Therapeutics (NASDAQ:UTHR) CEO Sells 9,500 Shares of Stock - MarketBeat

Insider Selling: United Therapeutics (NASDAQ:UTHR) CEO Sells 9,500 Shares of Stock  MarketBeat

Insider Selling: United Therapeutics (NASDAQ:UTHR) CEO Sells 9,500 Shares of Stock - MarketBeat

Click here to get full coverage on UBS Group Forecasts Strong Price Appreciation for United Therapeutics (NASDAQ:UTHR) Stock - MarketBeat

UBS Group Forecasts Strong Price Appreciation for United Therapeutics (NASDAQ:UTHR) Stock  MarketBeat

UBS Group Forecasts Strong Price Appreciation for United Therapeutics (NASDAQ:UTHR) Stock - MarketBeat

Click here to get full coverage on Why United Therapeutics (UTHR) Is Up 6.2% After Phase 3 Ralinepag Success And Strong Earnings - simplywall.st

Why United Therapeutics (UTHR) Is Up 6.2% After Phase 3 Ralinepag Success And Strong Earnings  simplywall.st

Why United Therapeutics (UTHR) Is Up 6.2% After Phase 3 Ralinepag Success And Strong Earnings - simplywall.st

Click here to get full coverage on UNITED THERAPEUTICS ($UTHR) Releases Q4 2025 Earnings - Quiver Quantitative

UNITED THERAPEUTICS ($UTHR) Releases Q4 2025 Earnings  Quiver Quantitative

UNITED THERAPEUTICS ($UTHR) Releases Q4 2025 Earnings - Quiver Quantitative

Click here to get full coverage on Assessing United Therapeutics (UTHR) Valuation As Long Term Returns Contrast With Softer Recent Momentum - Yahoo Finance

Assessing United Therapeutics (UTHR) Valuation As Long Term Returns Contrast With Softer Recent Momentum  Yahoo Finance

Assessing United Therapeutics (UTHR) Valuation As Long Term Returns Contrast With Softer Recent Momentum - Yahoo Finance

Click here to get full coverage on Unveiling United Therapeutics (UTHR) Q4 Outlook: Wall Street Estimates for Key Metrics - Yahoo Finance

Unveiling United Therapeutics (UTHR) Q4 Outlook: Wall Street Estimates for Key Metrics  Yahoo Finance

Unveiling United Therapeutics (UTHR) Q4 Outlook: Wall Street Estimates for Key Metrics - Yahoo Finance

Click here to get full coverage on United Therapeutics (UTHR) Q4 Earnings Report Preview: What To Look For - Finviz

United Therapeutics (UTHR) Q4 Earnings Report Preview: What To Look For  Finviz

United Therapeutics (UTHR) Q4 Earnings Report Preview: What To Look For - Finviz

Click here to get full coverage on United Therapeutics Corp (NASDAQ:UTHR) Emerges as a Peter Lynch-Style GARP Candidate - ChartMill

United Therapeutics Corp (NASDAQ:UTHR) Emerges as a Peter Lynch-Style GARP Candidate  ChartMill

United Therapeutics Corp (NASDAQ:UTHR) Emerges as a Peter Lynch-Style GARP Candidate - ChartMill

Click here to get full coverage on United Therapeutics Unveils $2 Bln Buyback Plan, Launches $1.5 Bln Accelerated Repurchase - TradingView

United Therapeutics Unveils $2 Bln Buyback Plan, Launches $1.5 Bln Accelerated Repurchase  TradingView

United Therapeutics Unveils $2 Bln Buyback Plan, Launches $1.5 Bln Accelerated Repurchase - TradingView

Click here to get full coverage on United Therapeutics (UTHR) Net Margin Strength Reinforces Bullish Earnings Narrative - simplywall.st

United Therapeutics (UTHR) Net Margin Strength Reinforces Bullish Earnings Narrative  simplywall.st

United Therapeutics (UTHR) Net Margin Strength Reinforces Bullish Earnings Narrative - simplywall.st

Click here to get full coverage on Insider Sell: Judy Olian Sells 200 Shares of United Therapeutics Corp (UTHR) - GuruFocus

Insider Sell: Judy Olian Sells 200 Shares of United Therapeutics Corp (UTHR)  GuruFocus

Insider Sell: Judy Olian Sells 200 Shares of United Therapeutics Corp (UTHR) - GuruFocus

Click here to get full coverage on Is United Therapeutics Corporation's (NASDAQ:UTHR) Recent Performance Tethered To Its Attractive Financial Prospects? - Yahoo Finance

Is United Therapeutics Corporation's (NASDAQ:UTHR) Recent Performance Tethered To Its Attractive Financial Prospects?  Yahoo Finance

Is United Therapeutics Corporation's (NASDAQ:UTHR) Recent Performance Tethered To Its Attractive Financial Prospects? - Yahoo Finance

Click here to get full coverage on H.C. Wainwright Maintains Buy on United Therapeutics (UTHR) Feb 2026 - Meyka

H.C. Wainwright Maintains Buy on United Therapeutics (UTHR) Feb 2026  Meyka

H.C. Wainwright Maintains Buy on United Therapeutics (UTHR) Feb 2026 - Meyka

Click here to get full coverage on Once-daily PAH drug by United Therapeutics slows progressive disease - Stock Titan

Once-daily PAH drug by United Therapeutics slows progressive disease  Stock Titan

Once-daily PAH drug by United Therapeutics slows progressive disease - Stock Titan

Click here to get full coverage on UTHR: Ralinepag and Tyvaso drive growth, with major advances in inhaled therapies and xenotransplantation - TradingView

UTHR: Ralinepag and Tyvaso drive growth, with major advances in inhaled therapies and xenotransplantation  TradingView

UTHR: Ralinepag and Tyvaso drive growth, with major advances in inhaled therapies and xenotransplantation - TradingView

Click here to get full coverage on United Therapeutics (UTHR) Earnings Expected to Grow: What to Know Ahead of Next Week's Release - Yahoo Finance

United Therapeutics (UTHR) Earnings Expected to Grow: What to Know Ahead of Next Week's Release  Yahoo Finance

United Therapeutics (UTHR) Earnings Expected to Grow: What to Know Ahead of Next Week's Release - Yahoo Finance

Click here to get full coverage on A Fresh Look at United Therapeutics (UTHR) Valuation After Strong Share Price Gains - Yahoo Finance

A Fresh Look at United Therapeutics (UTHR) Valuation After Strong Share Price Gains  Yahoo Finance

A Fresh Look at United Therapeutics (UTHR) Valuation After Strong Share Price Gains - Yahoo Finance

Click here to get full coverage on Causey (United Therapeutics) sells $9803 in UTHR stock By Investing.com - Investing.com Nigeria

Causey (United Therapeutics) sells $9803 in UTHR stock By Investing.com  Investing.com Nigeria

Causey (United Therapeutics) sells $9803 in UTHR stock By Investing.com - Investing.com Nigeria

Click here to get full coverage on Why United Therapeutics (UTHR) Is Up 6.2% After Phase 3 Ralinepag Success And Strong Earnings - Sahm

Why United Therapeutics (UTHR) Is Up 6.2% After Phase 3 Ralinepag Success And Strong Earnings  Sahm

Why United Therapeutics (UTHR) Is Up 6.2% After Phase 3 Ralinepag Success And Strong Earnings - Sahm

Click here to get full coverage on Therapeutics Stocks Q3 Highlights: United Therapeutics (NASDAQ:UTHR) - Yahoo Finance

Therapeutics Stocks Q3 Highlights: United Therapeutics (NASDAQ:UTHR)  Yahoo Finance

Therapeutics Stocks Q3 Highlights: United Therapeutics (NASDAQ:UTHR) - Yahoo Finance

Click here to get full coverage on United Therapeutics Corporation (UTHR): A Bull Case Theory - Yahoo Finance

United Therapeutics Corporation (UTHR): A Bull Case Theory  Yahoo Finance

United Therapeutics Corporation (UTHR): A Bull Case Theory - Yahoo Finance

Click here to get full coverage on Reassessing United Therapeutics (UTHR) Valuation After Strong 1 Year Share Price Performance - Yahoo Finance

Reassessing United Therapeutics (UTHR) Valuation After Strong 1 Year Share Price Performance  Yahoo Finance

Reassessing United Therapeutics (UTHR) Valuation After Strong 1 Year Share Price Performance - Yahoo Finance

Click here to get full coverage on Is It Time To Reassess United Therapeutics (UTHR) After Recent Pulmonary Hypertension Headlines? - simplywall.st

Is It Time To Reassess United Therapeutics (UTHR) After Recent Pulmonary Hypertension Headlines?  simplywall.st

Is It Time To Reassess United Therapeutics (UTHR) After Recent Pulmonary Hypertension Headlines? - simplywall.st

Click here to get full coverage on United Therapeutics (UTHR): Revisiting Valuation After Strong Multi‑Year Share Price Gains - Yahoo Finance

United Therapeutics (UTHR): Revisiting Valuation After Strong Multi‑Year Share Price Gains  Yahoo Finance

United Therapeutics (UTHR): Revisiting Valuation After Strong Multi‑Year Share Price Gains - Yahoo Finance

Click here to get full coverage on MannKind, Liquidia fall as United Therapeutics mulls new treprostinil formulation - Seeking Alpha

MannKind, Liquidia fall as United Therapeutics mulls new treprostinil formulation  Seeking Alpha

MannKind, Liquidia fall as United Therapeutics mulls new treprostinil formulation - Seeking Alpha

Click here to get full coverage on Oppenheimer Raises United Therapeutics (UTHR) Price Target to $6 - GuruFocus

Oppenheimer Raises United Therapeutics (UTHR) Price Target to $6  GuruFocus

Oppenheimer Raises United Therapeutics (UTHR) Price Target to $6 - GuruFocus

Click here to get full coverage on United Therapeutics Q4 Earnings: Sky May Be The Limit For This Management Team (UTHR) - Seeking Alpha

United Therapeutics Q4 Earnings: Sky May Be The Limit For This Management Team (UTHR)  Seeking Alpha

United Therapeutics Q4 Earnings: Sky May Be The Limit For This Management Team (UTHR) - Seeking Alpha

Click here to get full coverage on United Therapeutics(UTHR.US) Officer Sells US$4.01 Million in Common Stock - 富途牛牛

United Therapeutics(UTHR.US) Officer Sells US$4.01 Million in Common Stock  富途牛牛

United Therapeutics(UTHR.US) Officer Sells US$4.01 Million in Common Stock - 富途牛牛

Click here to get full coverage on Why United Therapeutics (UTHR) Shares Are Sliding Today - FinancialContent

Why United Therapeutics (UTHR) Shares Are Sliding Today  FinancialContent

Why United Therapeutics (UTHR) Shares Are Sliding Today - FinancialContent

Click here to get full coverage on United Therapeutics (UTHR) Reports Q3: Everything You Need To Know Ahead Of Earnings - Yahoo Finance

United Therapeutics (UTHR) Reports Q3: Everything You Need To Know Ahead Of Earnings  Yahoo Finance

United Therapeutics (UTHR) Reports Q3: Everything You Need To Know Ahead Of Earnings - Yahoo Finance

Click here to get full coverage on AustralianSuper Pty Ltd Cuts Stake in United Therapeutics Corporation $UTHR - MarketBeat

AustralianSuper Pty Ltd Cuts Stake in United Therapeutics Corporation $UTHR  MarketBeat

AustralianSuper Pty Ltd Cuts Stake in United Therapeutics Corporation $UTHR - MarketBeat

Click here to get full coverage on United Therapeutics (UTHR) Beats Q3 Earnings Estimates - Yahoo Finance

United Therapeutics (UTHR) Beats Q3 Earnings Estimates  Yahoo Finance

United Therapeutics (UTHR) Beats Q3 Earnings Estimates - Yahoo Finance

Click here to get full coverage on United Therapeutics (NASDAQ:UTHR) Reports Sales Below Analyst Estimates In Q3 Earnings - Yahoo Finance

United Therapeutics (NASDAQ:UTHR) Reports Sales Below Analyst Estimates In Q3 Earnings  Yahoo Finance

United Therapeutics (NASDAQ:UTHR) Reports Sales Below Analyst Estimates In Q3 Earnings - Yahoo Finance

Click here to get full coverage on United Therapeutics Corp (UTHR) Q3 2025 Earnings Call Highlights: Record Revenue Growth and ... - Yahoo Finance

United Therapeutics Corp (UTHR) Q3 2025 Earnings Call Highlights: Record Revenue Growth and ...  Yahoo Finance

United Therapeutics Corp (UTHR) Q3 2025 Earnings Call Highlights: Record Revenue Growth and ... - Yahoo Finance

Click here to get full coverage on UTHR Stock Hits Record High on Tyvaso Meeting IPF Study Goals - Zacks Investment Research

UTHR Stock Hits Record High on Tyvaso Meeting IPF Study Goals  Zacks Investment Research

UTHR Stock Hits Record High on Tyvaso Meeting IPF Study Goals - Zacks Investment Research

Click here to get full coverage on Assessing United Therapeutics (UTHR) Valuation After Robust Double-Digit Growth and Recent Share Price Surge - Yahoo Finance

Assessing United Therapeutics (UTHR) Valuation After Robust Double-Digit Growth and Recent Share Price Surge  Yahoo Finance

UTHR

Price Chart

Key Statistics

Technicals

About UTHR

Latest News

United Therapeutics (UTHR) Surges 10.7%: Is This an Indication of Further Gains? - Yahoo Finance

Avoiding Lag: Real-Time Signals in (UTHR) Movement - Stock Traders Daily

Martine Rothblatt Sells 9,500 Shares of United Therapeutics (NASDAQ:UTHR) Stock - MarketBeat

Advanced Charts

Top Gainers

Top Losers